▼ SELL
$ Value
$94K
Shares
6,580
Price
$14
Filed
Dec 3
Insider
Name
Bedrosian Camille L
Title
Chief Medical Officer
CIK
0001326969
Roles
Officer
Transaction Details
Transaction Date
2025-12-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
175,756
Footnotes
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.30 to $14.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Filing Info
Bedrosian Camille L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-02 | AMLX | ▼ | $94K |
| 2025-12-01 | AMLX | ▼ | $94K |
| 2025-09-30 | AMLX | ▼ | $176K |
| 2025-06-24 | RYTM | A | $0 |
| 2025-06-24 | RYTM | A | $0 |
| 2025-06-18 | RYTM | M | — |
| 2025-06-18 | RYTM | M | $0 |
| 2025-06-11 | CRNX | A | $0 |
Other Insiders at AMLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
FRATES JAMES M
Chief Financial Officer
|
— | $167K | 2026-03-05 |
|
Bedrosian Camille L
Chief Medical Officer
|
— | $94K | 2026-03-05 |
|
Klee Justin B.
Co-Chief Executive Officer
|
— | $651K | 2026-03-05 |
|
Cohen Joshua B
Co-Chief Executive Officer
|
— | $652K | 2026-03-05 |
|
Mazzariello Gina
Chief Legal Officer
|
— | $198K | 2026-03-05 |